Assistant Research Fellow
Evie is interested in the genetics of heart disease, and is currently working to develop new tools to identify patients who will go on to have adverse cardiac remodelling or atrial fibrillation following a heart attack. This research involves identifying new genetic risk markers, and using these to build genetic risk scores and identify the pathways which promote these adverse outcomes.
Evie completed her PhD (2021) with the Christchurch Heart Institute at the University of Otago, Christchurch. Her PhD focussed on identifying circulating microRNA and protein biomarkers of Acute Kidney Injury in patients with heart failure, and involved utilising SWATH Mass Spectrometry and large-scale RTqPCR.
Templeton, E. M. (2021). Using non-coding RNAs and proteins to predict acute injury in heart failure (PhD). University of Otago, Dunedin, New Zealand. Retrieved from http://hdl.handle.net/10523/12004
Stamp, L. K., Cameron, V. A., Woodfield, T. B. F., Walker, L., Currie, M., Templeton, E., Pilbrow, A. P., Tabakakis, K., Phillips, E., & Lim, K. S. (2021). Impact of COVID-19 on health research in New Zealand: A case study of a research-intensive campus. Journal of the Royal Society of New Zealand. Advance online publication. doi: 10.1080/03036758.2020.1867202
Templeton, E. M., Cameron, V. A., Pickering, J. W., Richards, A. M., & Pilbrow, A. P. (2021). Emerging microRNA biomarkers for acute kidney injury in acute decompensated heart failure. Heart Failure Reviews, 26, 1203-1217. doi: 10.1007/s10741-020-09928-w
Ellmers, L. J., Templeton, E. M., Pilbrow, A. P., Frampton, C., Ishii, I., Moore, P. K., Bhatia, M., Richards, A. M., & Cameron, V. A. (2020). Hydrogen sulfide treatment improves post-infarct remodeling and long-term cardiac function in CSE knockout and wild-type mice. International Journal of Molecular Sciences, 21(12), 4284. doi: 10.3390/ijms21124284